2,2,5,7,8-pentamethyl-1-hydroxychroman has been researched along with nifedipine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barclay, LR; Ingold, KU; Lin, S; Litwinienko, G; MacLean, PD; Mulder, P | 1 |
| Baartscheer, A; Berecki, G; Casini, S; Coronel, R; den Ruijter, HM; Fiolet, JW; Hovenier, R; Opthof, T; Schumacher, CA; van Ginneken, AC; Veldkamp, MW; Verkerk, AO; Zock, PL | 1 |
2 other study(ies) available for 2,2,5,7,8-pentamethyl-1-hydroxychroman and nifedipine
| Article | Year |
|---|---|
The L-type calcium channel blockers, hantzsch 1,4-dihydropyridines, are not peroxyl radical-trapping, chain-breaking antioxidants.
Topics: Acridines; Antioxidants; Benzene Derivatives; Biphenyl Compounds; Calcium Channel Blockers; Calcium Channels, L-Type; Chromans; Dihydropyridines; Free Radicals; Hydrazines; Kinetics; Nifedipine; Nimodipine; Oxidation-Reduction; Peroxides; Picrates; Styrene | 2006 |
Incorporated sarcolemmal fish oil fatty acids shorten pig ventricular action potentials.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Action Potentials; Animals; Antioxidants; Arrhythmias, Cardiac; Calcium Channel Blockers; Calcium Channels; Chromans; Diet; Fatty Acids, Omega-3; Fish Oils; Heart Ventricles; Male; Membrane Potentials; Myocytes, Cardiac; Nifedipine; Patch-Clamp Techniques; Sarcolemma; Sodium Channels; Sodium-Calcium Exchanger; Swine; Time Factors | 2006 |